Bumper Offer - Urjas oil Just @ Rs. 1
S Vocita 5 Tablet, a prescription drug, is manufactured in various forms such as Tablet. Depression are some of its major therapeutic uses. Other than this, S Vocita 5 Tablet has some other therapeutic uses, which have been discussed ahead.
The right dosage of S Vocita 5 Tablet depends on the age, gender, and medical history of the patient. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Detailed information has been provided in the dosage section.
Besides the aforementioned side effects, there are other adverse effects of S Vocita 5 Tablet as well, which are listed below. Usually, these side effects of S Vocita 5 Tablet go away soon, and do not persist beyond the duration of the treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
In addition, S Vocita 5 Tablet's effect is Moderate during pregnancy and Severe for lactating mothers. Further, the section on S Vocita 5 Tablet related warnings talks about S Vocita 5 Tablet's effects on the liver, heart and kidney.
Other conditions have been mentioned below in the S Vocita 5 Tablet contraindications section.
Drug reaction of S Vocita 5 Tablet with other medicines has been reported. A complete list of these interactions is given below.
In addition to the above precautions for S Vocita 5 Tablet, it is important to know that it is not safe while driving, and is not habit-forming.
S Vocita 5 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Adult(Male) |
|
| Geriatric |
|
Based on research, the following side effects have been observed when S Vocita 5 Tablet is used -
Moderate
Mild
Is the use of S Vocita 5 Tablet safe for pregnant women?
S Vocita can cause unwanted side effects in pregnant women. If you experience any side effects, stop taking S Vocita right away. Take your doctor's advice before taking it again.
Is the use of S Vocita 5 Tablet safe during breastfeeding?
Taking S Vocita may lead to serious side effects if you are breastfeeding. S Vocita should not be taken by breastfeeding women unless prescribed by the doctor.
What is the effect of S Vocita 5 Tablet on the Kidneys?
S Vocita rarely harms the kidneys.
What is the effect of S Vocita 5 Tablet on the Liver?
S Vocita is rarely harmful for the liver.
What is the effect of S Vocita 5 Tablet on the Heart?
S Vocita is rarely harmful for the heart.
S Vocita 5 Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take S Vocita 5 Tablet unless your doctor advises you to do so -
Is this S Vocita 5 Tablet habit forming or addictive?
No, you will not get addicted to S Vocita 5 Tablet.
Is it safe to drive or operate heavy machinery when consuming?
After taking S Vocita 5 Tablet, you should not drive or work on any heavy machine, as S Vocita 5 Tablet can make you drowsy.
Is it safe?
S Vocita 5 Tablet should be used only after doctor's advice.
Is it able to treat mental disorders?
S Vocita 5 Tablet has been seen to have positive effect on patients with mental disorders.
Interaction between Food and S Vocita 5 Tablet
Taking S Vocita 5 Tablet with food does not cause any problems.
Interaction between Alcohol and S Vocita 5 Tablet
Consumption of alcohol and S Vocita 5 Tablet together may have severe effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lexapro® (escitalopram oxalate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 461
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 520-522
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lexapro® (escitalopram oxalate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 461
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 520-522
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lexapro® (escitalopram oxalate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 461
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 520-522
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lexapro® (escitalopram oxalate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 461
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 520-522
